Skip to main content

Advertisement

Log in

Preclinical safety assessment of contrast media: predictive value

  • Published:
European Radiology Aims and scope Submit manuscript

Abstract

The purpose of preclinical tests is to identify the potential benefits and risks of new diagnostic or therapeutic products. Regarding iodinated contrast media (CM), LD50 tests were used extensively in the past. However, from both scientific and ethical perspectives it is today highly relevant to question the use of LD50 tests. Due to species differences and the very high volume of CM needed to kill half of the animals, such tests are not sensitive enough to differentiate between modern nonionic CM. Further, they are not very predictive in terms of human tolerability. In other tests with more relevant end-points than death, overall tolerance to the new dimeric compound iodixanol (Visipaque), representing the latest step in the development of CM, has been shown to be higher than to tire nonionic monomers. Clinical experience has shown that the physiological parameters often stay closer to baseline alter Visipaque than after administration of conventional CM.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Almén T (1989) Relationship between chemical structure, animal toxicity and clinical adverse effects of contrast media. In: Enge I, Edgren J (eds) Patient Safety and Adverse Events in Contrast Medium Examinations. Excerpta Medica International Congress Series 816, Elsevier Sciences Publisher, Amsterdam, pp 25–45

    Google Scholar 

  2. Almén T (1969) Contrast agent design. Some aspects on the synthesis of water-soluble contrast agents of low osmolality. J Theor Biol 24:216–226

    PubMed  Google Scholar 

  3. Almén T (1985) Development of nonionic contrast media. Invest Radiol 20:S2-S9

    PubMed  Google Scholar 

  4. Karlsson JOG, Gregersen M, Refsum H (1995) Visipaque is isotonic to human and rat blood plasma. Acta Radiol Suppl 399,39–42

    CAS  PubMed  Google Scholar 

  5. de Haen C, Morisetti A, Bertani F, Tirone P (1994) The factor time in acute intravenous toxicity studies of contrast media. Invest Radiol 29:S108-S110

    PubMed  Google Scholar 

  6. Morisetti A, Tirone P, Luzzani F, de Haen C (1994) Toxicological safety assessment of iomeprol, a new X-ray contrast agent. Eur J Radiol 18:S21-S31

    PubMed  Google Scholar 

  7. Trevan JW (1927) The error of determination of toxicity. Proc R Soc Lond (Biol) 101:483–514

    Google Scholar 

  8. Katayama H, Yamaguchi K, Kozuka T, Takashima, Seez P, Matsuura K (1990) Adverse reaction to ionic and nonionic contrast media. A report from the Japanese Committee on Safety of Contrast Media. Radiology 175:621–628

    CAS  PubMed  Google Scholar 

  9. Russel WMS, Burch RE (1959) The principles of Human Experimental Technique, Meuthen, London

    Google Scholar 

  10. Rang HP, Dale MM (1987) Pharmacology, Churchill Livingstone, Edinburgh

    Google Scholar 

  11. Ekwall B, Bondesson I, Castell JV, Gomez-Lecho'n MJ, Helberg S, Högberg J, Jover R, Ponsoda X, Rombert L, Stenberg K, Walum E (1989) Cytotoxicity evaluation of the first ten MEIC chemicals: acute lethal toxicity in man predicted by cytotoxicity in five cellular assays and by oral LD50 tests in rodents. Alternative to Laboratory Animals 17:83–100

    Google Scholar 

  12. Speck U (1994) Principles and aims of preclinical testing. Invest Radiol 29:S15-S20

    PubMed  Google Scholar 

  13. Heglund IF, Blazak W, Michelet ÅA, Furuhama K, Holtz E (1995) Preclinical pharmacokinetics and general toxicology of iodixanol. Acta Radiol Suppl 399,69–82

    CAS  PubMed  Google Scholar 

  14. Hull RM (1995) Guideline limit volumes for dosing animals in the preclinical stage of safety evaluation. Human Exp Toxicol 14:305–307

    CAS  Google Scholar 

  15. Michelet AA (1987) Effects of intravascular contrast media on the blood-brain barrier. Comparison between iothalamate, iohexol, iopentol and iodixanol. Acta Radiol 28:329–333

    CAS  Google Scholar 

  16. Larsen LE, Heglund IF, Fabian R, Walday P, Blazak WF (1995) Neural tolerance of iodixanol in mice and dogs after a single and repeated intracisternal administration. Acta Radiol Suppl 399, 238–243

    CAS  PubMed  Google Scholar 

  17. Maly P, Sundgren P, Bååth L, Golman K, Walday P (1995) Adverse reactions in myelography. Correlation between animal research and clinical practice. Acta Radiol Suppl 399,230–237

    CAS  PubMed  Google Scholar 

  18. Almén T (1987) Effects of iodixanol, iopentol, iohexol and metrizoate on femoral blood flow after injection into the femoral artery in the dog. Acta Radiol Suppl 370,69–72

    PubMed  Google Scholar 

  19. Kløw NE, Mortensen E, Refsum H (1991) Left ventricular systolic and diastolic function during coronary arteriography before and after acute left ventricular failure in dogs. Acta Radiol 32:124–129

    PubMed  Google Scholar 

  20. Bååth L, Besjakov J, Øksendal AN (1993) Calcium and sodium addition to non-ionic contrast media. Invest Radiol 28:223–227

    PubMed  Google Scholar 

  21. Jynge P, Holten T, Øksendal AN (1993) Sodium-calcium balance and cardiac function with isotonic iodixanol: an experimental study in the isolated rat heart. Invest Radiol 28: 20–25

    CAS  PubMed  Google Scholar 

  22. Dunkel JA, Bøkenes J, Karlsson JOG, Refsum H (1995) Cardiac effects of iodixanol compared to those of other non-ionic and ionic contrast media in the isolated rat heart. Acta Radiol Suppl 399,142–154

    CAS  PubMed  Google Scholar 

  23. Morris TW, Dukovik D, Pagani E (1994) The effects of coronary injection of iodixanol, iopamidol, and ioxaglate on contractility and electrophysiology. Invest Radiol 29:S99-S101

    CAS  PubMed  Google Scholar 

  24. Pedersen HK, Jacobsen EA, Refsum H (1994) Contrast-media induced ventricular fibrillation: An experimental study of the effects of dimeric contrast media during wedged catheter injection in dogs. Acad Radiol 1:136–144

    Article  CAS  PubMed  Google Scholar 

  25. Karlsson JOG, Gregersen M, Bøkeness J, Pugh ND, Griffith TM, Refsum H (1995) Nonionic dimers produce less vasodilation than nonionic monomers in vitro. Eur Radiol 5:S354 An Abstract

    Google Scholar 

  26. Pugh ND, Hutcheson IR, Edwards DH, Nossen JØ, Karlsson JOG, Griffith TM (1995) Angiographic contrast media relax isolated rabbit aorta through an endothelium-independent mechanism that may not depend on the presence of the iodine atom. Br J Radiol 68:23–26

    CAS  PubMed  Google Scholar 

  27. Walday P, Heglund IF, Golman K, Cornacoff J, Holtz E (1995) Renal effects of iodixanol in experimental animals. Acta Radiol Suppl 399,204–212

    CAS  PubMed  Google Scholar 

  28. Grynne BH, Bolstad B, Borch KW, Nossen JØ (1995) Main results from the first comparative clinical studies with Visipaque. Acta Radiol Suppl 399,265–270

    CAS  PubMed  Google Scholar 

  29. Katz AM (1992) Physiology of the Heart. Raven Press Ltd, New York

    Google Scholar 

  30. Pugh ND, Sisson GRJ, Ruttley MST, Berg KJ, Nossen JØ, Eide H (1993) Iodixanol in femoral arteriography (phase III): A comparative double-blind parallel trial between iodixanol and iopromide. Clin Radiol 47:96–99

    CAS  PubMed  Google Scholar 

  31. Verow P, Nossen JØ, Sheppick A, Kjærsgaard P (1995) A comparison of iodixanol with iopamidol in aorto-femoral angiography. Br J Radiol 68:973–978

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Karlsson, J.O.G. Preclinical safety assessment of contrast media: predictive value. Eur. Radiol. 6 (Suppl 2), S3–S7 (1996). https://doi.org/10.1007/BF02342564

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02342564

Keywords

Navigation